Renal angiotensin converting enzyme promotes renal damage during ureteral obstruction

Journal of Urology

Volumn 160, Issue 3 II, 1998, Pages 1070-1074

  Stoneking, Bradley J ^a   Hunley, Tracy E ^a   Nishimura, Hideki ^a   Ma, Ji ^a   Fogo, Agnes ^a   Inagami, Tadashi ^a   Tamura, Masaaki ^a   Adams, Mark C ^a   Brock III, John W ^a   Kon, Valentina ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Kidney; Peptidyl dipeptidase A; Ureter

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; KIDNEY INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; URETER OBSTRUCTION;

EID: 0032322336     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62699-5     Document Type: Conference Paper

References (42)

1. Foreman, J. W. and Chan, J. C. M.: Chronic renal failure in infants and children. J. Ped., 113: 793, 1988.
2. Smellie, J. M. and Normand, I. C. S.: Reflux nephropathy in childhood. In: Reflux Nephropathy. Edited by J. Hodson and P. Kincaid-Smith. New York: Masson Publishing, pp. 14-20, 1979.
3. Wolf, G. and Neilson, E. G.: Angiotensin II as a renal growth factor. J. Amer. Soc. Nephrol., 3: 1531, 1993.
4. Klahr, S., Ishidoya, S. and Morrissey, J.: Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Amer. J. Kidney Dis., 26: 141, 1995.
5. Klahr, S. and Purkerson, M. L.: The pathophysiology of obstructive nephropathy: the role of vasoactive compounds in the hemodynamic and structural abnormalities of the obstructed kidney. Amer. J. Kidney Dis., 23: 219, 1994.
6. Anderson, S., Rennke, H. G. and Brenner, B. M.: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J. Clin. Invest., 77: 1993, 1986.
7. Cattran, D. C., Greenwood, C. and Ritchie, S.: Long-term benefit of angiotensin converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Amer. J. Kidney Dis., 23: 247, 1994.
8. Lewis, E. J., Hunsicker, L. G., Bain, R. P. and Rohde, R. D.: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. New Engl. J. Med., 329: 1456, 1993.
9. Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J. F. E., Motolese, M., Ponticelli, C., Ritz, E. and Zucchelli, P.: Effect of angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. New Engl. J. Med., 334: 939, 1996.
10. Ishidoya, S., Morrissey, J., McCracken, R., Reyes, A. and Klahr, S.: Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int., 47: 1285, 1995.
11. Chevalier, R. L. and Thornhill, B. A.: Ureteral obstruction in the neonatal guinea pig: interaction of sympathetic nerves and angiotensin. Ped. Nephrol., 9: 441, 1995.
12. Morishita, R., Gibbons, G. H., Ellison, K. E., Lee, W., Zhang, L., Yu, H., Kaneda, Y., Ogihara, T. and Dzau, V. J.: Evidence for direct local effect of angiotensin in vascular hypertrophy: in vivo gene transfer of angiotensin converting enzyme. J. Clin. Invest., 94: 978, 1994.
13. Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J. P., Arveiler, D., Luc, G., Bard, J. M., Bara, L., Ricard, S., Tiret, L., Amouyel, P., Alhenc-Gelas, F. and Soubrier, F.: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature, 359: 641, 1992.
14. Schunkert, H., Hense, H. W., Holmer, S. R., Stender, M., Perz, S., Keil, U., Lorell, B. H. and Riegger, G. A. J.: Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. New Engl. J. Med., 330: 1634, 1994.
15. Hunley, T., Julian, B. A., Phillips, J. A., III, Summar, M. L., Yoshida, H., Horn, R, G., Brown, N. J., Fogo, A., Ichikawa, I. and Kon, V.: Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int., 49: 571, 1996.
16. Harden, P. N., Geddes, C., Rowe, P. A., McIlroy, J. H., Boulton Jones, M., Roger, R. S., Junor, B. J., Briggs, J. D., Connell, J. M. and Jardin, A. G.: Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet, 345: 1540, 1995.
17. Yorioka, T., Suehiro, T., Yasuoka, N., Hashimoto, K. and Kawada, M.: Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy. Clin. Nephrol., 44: 80, 1995.
18. Yoshida, H., Hamaguchi, A., Mitarai, T., Kuriyama, S., Kawamura, T., Tomonari, H., Eto, T., Kubo, H., Kawaguchi, Y., Matsuoka, K., Atsumi, Y., Ichikawa, I. and Sakai, O.: Accelerated progression to renal failure in NIDDM patients with the deletion polymorphism of the angiotensin converting enzyme (ACE) gene. J. Amer. Soc. Nephrol., 6: 409, 1995.
19. Brock, J. W., III, Adams, M., Hunley, T., Wada, A., Trusler, L. and Kon, V.: Potential risk factors associated with progressive renal damage in childhood urologic diseases: the role of angiotensin-converting enzyme gene polymorphism. J. Urol., 158: 1308, 1997.
20. Lieberman, J. and Sastre, A.: Angiotensin-converting enzyme activity in postmortem human tissues. Lab. Invest., 48: 711, 1983.
21. Ichiki, T., Labosky, P. A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., Niimura, F., Ichikawa, I., Hogan, B. L. and Inagami, T.: Effects of blood pressure and exploratory behavior of mice lacking angiotensin II type-2 receptor. Nature, 377: 748, 1995.
22. Morishita, R., Gibbons, G. H., Ellison, K. E., Lee, W., Zhang, L., Yu, H., Kaneda, Y., Ogihara, T. and Dzau, V. J.: Evidence for direct local effect of angiotensin in vascular hypertrophy: in vivo gene transfer of angiotensin converting enzyme. J. Clin. Invest., 94: 978, 1994.
23. Prescott, M. F., Webb, R. L. and Reidy, M. A.: Angiotensin converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist: effects on smooth muscle cell migration and proliferation after balloon catheter injury. Amer. J. Path., 139: 1291, 1991.
24. Dzau, V. J., Gibbons, G. H. and Pratt, R. E.: Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension, 18: 100, 1991.
25. Yamada, T., Horiuchi, M. and Dzau, V. J.: Angiotensin II type 2 receptor mediates programmed cell death. Proc. Natl. Acad Sci., 93: 156, 1996.
26. Tanaka, M., Ohnishi, J., Ozawa, Y., Sugimoto, M., Usuki, S., Naruse, M., Murakami, K. and Miyazaki, H.: Characterization of angiotensin II receptor type 2 during differentiation and apoptosis of rat ovarian cultured granulosa cells. Biochem. Biophys. Res. Comm., 207: 593, 1995.
27. Viswanathan, M. and Saavedra, J. M.: Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing. Peptides, 13: 783, 1992.
28. Janiak, P., Pillon, A., Prost, J. F. and Vilaine, J. P.: Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension, 20: 737, 1992.
29. Nio, Y., Matsubara, H., Murasawa, S., Kanasaki, M. and Inada, M.: Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J. Clin. Invest., 95: 46, 1995.
30. Brink, M., Erne, P., de Gasparo, M., Rogg, H., Schmid, A., Stulz, P. and Bullock, G.: Localization of the angiotensin II receptor subtypes in the human atrium. J. Molec. Cell. Cardiol., 28: 1789, 1996.
31. Ma, J., Nishimura, H., Fogo, A., Kon, V., Inakami, T. and Ichikawa, I.: Accelerated fibrosis and collagen deposition develop in the renal interstitium of AT2 receptor null mutant mice during experimental ureteral obstruction. J. Amer. Soc. Nephrol., 8: 622A, 1997.
32. Kon, V., Hunley, T. and Fogo, A.: Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis: studies in chronic cyclosporine nephrotoxicity in rats. Transplantation, 60: 89, 1995.
33. Meng, Q. C., Balcells, E., Dell'Italia, L., Durand, J. and Oparil, S.: Sensitive method for quantitation of angiotensin-converting enzyme (ACE) activity in tissue. Biochem. Pharmacol., 50: 1445, 1995.
34. Wei, L., Alhenc-Gelas, F., Soubrier, F., Michaud, A., Corvol, P. and Clauser, E.: Expression and characterization of recombinant human angiotensin I-converting enzyme. J. Biol. Chem., 266: 5540, 1991.
35. Lama, G., Salsano, M. E., Pedulla, M., Grassia, C. and Ruocco, G.: Angiotensin converting enzyme inhibitors and reflux nephropathy: 2-year follow-up. Ped. Nephrol., 11: 714, 1997.
36. Kagami, S., Border, W. A., Miller, D. E. and Noble, N. A.: Angiotensin II stimulates matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J. Clin. Invest., 93: 2431, 1994.
37. Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P. and Soubrier, F.: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest., 86: 1343, 1990.
38. Danser, A. H. J., Schalekamp, M. A. D. H., Bax, W. A., van den Brink, A. M., Saxena, P. R., Riegger, G. A. J. and Schundert, H.: Angiotensin-converting enzyme in the human heart. Circulation, 92: 1387, 1995.
39. Costerousse, O., Allegrini, J., Lopez, M. and Alhenc-Gelas, F.: Angiotensin I converting enzyme in human circulatory mononuclear cells: genetic polymorphism of expression in T lymphocytes. Biochem. J., 290: 33, 1993.
40. Marre, M., Jeunemaitre, X., Gallois, Y., Rodier, M., Chatellier, G., Sert, C., Dusselier, L., Kahal, Z., Chaillous, L., Halimi, S., Muller, A., Sackman, H., Bauduceau, B., Bled, F., Passa, P. and Alhenc-Gelas, F.: Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J. Clin. Invest., 99: 1585, 1997.
41. Yoshida, H., Kuriyama, S., Atsumi, Y., Tomonari, H., Mitarai, T., Hamaguchi, A., Kubo, H., Kawaguchi, Y., Kon, V., Matsuoka, K., Ichikawa, I. and Sakai, O.: Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int., 50: 657, 1996.
42. Rakugi, H., Kim, D. K., Krieger, J. E., Wang, D. S., Dzau, V. J. and Pratt, R. E.: Induction of angiotensin converting enzyme in the neointima after vascular injury: possible role in restenosis. J. Clin. Invest., 93: 339, 1994.